{"hands_on_practices": [{"introduction": "To understand the glymphatic system's importance, we must first answer a fundamental question: how does it clear waste more effectively than simple diffusion? This exercise guides you through a dimensional analysis of the convection-diffusion equation to compare the timescales of these two transport mechanisms. By calculating a key dimensionless ratio, the Péclet number, you can quantitatively determine which process—bulk fluid flow (convection) or random molecular motion (diffusion)—dominates waste clearance over relevant distances in the brain [@problem_id:5071277].", "problem": "Glymphatic transport in the sleeping cortex is thought to be enhanced by increased cerebrospinal fluid (CSF) influx into paravascular spaces, promoting interstitial advection that augments molecular diffusion. Consider an amyloid-$\\beta$ solute moving from cortical parenchyma toward perivenous drainage over a characteristic distance $L$, within tissue where the effective diffusivity is $D$ and where sleep-associated interstitial flow provides a roughly uniform advective velocity $U$. Assume the solute is not degraded or produced and that the medium is homogeneous and isotropic at the scale of interest.\n\nStarting from the convection–diffusion equation for concentration $c(\\mathbf{x},t)$,\n$$\n\\frac{\\partial c}{\\partial t}+\\mathbf{U}\\cdot\\nabla c=D\\,\\nabla^{2}c,\n$$\nuse dimensional analysis with characteristic spatial scale $L$ and characteristic time scales for diffusion and advection to obtain expressions for the diffusion-dominated clearance time and the advection-dominated clearance time. Define the dimensionless ratio $R$ between these two characteristic times and evaluate it for the following physiologically plausible cortical sleep parameters:\n- $L=4.0\\times 10^{-4}\\ \\mathrm{m}$,\n- $D=8.0\\times 10^{-11}\\ \\mathrm{m^{2}\\,s^{-1}}$,\n- $U=8.0\\times 10^{-7}\\ \\mathrm{m\\,s^{-1}}$.\n\nBased on the magnitude of $R$, conclude which mechanism clears amyloid-$\\beta$ faster during sleep, but report only the numerical value of $R$ as your final answer. Round your final value of $R$ to $3$ significant figures. Express $R$ as a dimensionless number (no units).", "solution": "The problem is valid as it is scientifically grounded in the principles of transport phenomena, specifically the convection-diffusion equation, applied to the context of neurobiology. The problem is well-posed, objective, and provides all necessary information and consistent parameters to arrive at a unique solution.\n\nThe transport of a solute, such as amyloid-$\\beta$, within the brain's interstitial space is described by the convection–diffusion equation. The concentration of the solute, $c(\\mathbf{x}, t)$, evolves according to the partial differential equation provided:\n$$\n\\frac{\\partial c}{\\partial t}+\\mathbf{U}\\cdot\\nabla c=D\\,\\nabla^{2}c\n$$\nHere, $\\frac{\\partial c}{\\partial t}$ is the rate of change of concentration at a point (the transient term), $\\mathbf{U}\\cdot\\nabla c$ represents transport due to bulk fluid flow (advection), and $D\\,\\nabla^{2}c$ represents transport due to random molecular motion (diffusion). We are given a uniform advective velocity field $\\mathbf{U}$ with magnitude $U$, an effective diffusivity $D$, and a characteristic length scale $L$ over which the solute is cleared.\n\nTo determine the characteristic time scales for clearance, we perform a dimensional analysis of the governing equation. We can approximate the derivatives using the characteristic scales.\nThe spatial derivative operator $\\nabla$ scales as $1/L$, and the Laplacian operator $\\nabla^2$ scales as $1/L^2$. The temporal derivative $\\frac{\\partial}{\\partial t}$ scales as $1/t_{char}$, where $t_{char}$ is a characteristic time scale.\nSubstituting these scales into the equation gives an order-of-magnitude balance:\n$$\n\\frac{[c]}{t_{char}} + \\frac{U [c]}{L} \\sim \\frac{D [c]}{L^2}\n$$\nwhere $[c]$ is the characteristic concentration scale. The concentration scale $[c]$ cancels from all terms.\n\nTo find the diffusion-dominated clearance time, which we will denote as $t_{diff}$, we consider a scenario where diffusion is the primary mechanism for transport. This means we balance the transient term with the diffusion term, assuming the advection term is negligible:\n$$\n\\frac{\\partial c}{\\partial t} \\approx D\\,\\nabla^{2}c\n$$\nIn terms of characteristic scales, this balance becomes:\n$$\n\\frac{1}{t_{diff}} \\sim \\frac{D}{L^2}\n$$\nSolving for $t_{diff}$ yields the characteristic time for diffusion over a distance $L$:\n$$\nt_{diff} \\sim \\frac{L^2}{D}\n$$\n\nTo find the advection-dominated clearance time, denoted as $t_{adv}$, we consider a scenario where advection is the primary transport mechanism. We balance the transient term with the advection term, assuming the diffusion term is negligible:\n$$\n\\frac{\\partial c}{\\partial t} \\approx - \\mathbf{U}\\cdot\\nabla c\n$$\nIn terms of characteristic scales, this balance becomes:\n$$\n\\frac{1}{t_{adv}} \\sim \\frac{U}{L}\n$$\nSolving for $t_{adv}$ yields the characteristic time for advection over a distance $L$:\n$$\nt_{adv} \\sim \\frac{L}{U}\n$$\n\nThe problem asks for the dimensionless ratio $R$ of the diffusion-dominated clearance time to the advection-dominated clearance time:\n$$\nR = \\frac{t_{diff}}{t_{adv}}\n$$\nSubstituting the expressions we derived for the characteristic times:\n$$\nR = \\frac{L^2/D}{L/U} = \\frac{L^2}{D} \\cdot \\frac{U}{L} = \\frac{UL}{D}\n$$\nThis dimensionless number is known as the Péclet number ($Pe$), which compares the rate of advective transport to the rate of diffusive transport.\n\nWe are given the following physiological parameters:\n- $L = 4.0 \\times 10^{-4}\\ \\mathrm{m}$\n- $D = 8.0 \\times 10^{-11}\\ \\mathrm{m^{2}\\,s^{-1}}$\n- $U = 8.0 \\times 10^{-7}\\ \\mathrm{m\\,s^{-1}}$\n\nNow, we can substitute these values into the expression for $R$:\n$$\nR = \\frac{(8.0 \\times 10^{-7}\\ \\mathrm{m\\,s^{-1}}) \\times (4.0 \\times 10^{-4}\\ \\mathrm{m})}{8.0 \\times 10^{-11}\\ \\mathrm{m^{2}\\,s^{-1}}}\n$$\nThe units cancel out as expected: $\\frac{(\\mathrm{m/s}) \\cdot \\mathrm{m}}{\\mathrm{m^2/s}} = \\frac{\\mathrm{m^2/s}}{\\mathrm{m^2/s}}$.\n$$\nR = \\frac{8.0 \\times 4.0}{8.0} \\times \\frac{10^{-7} \\times 10^{-4}}{10^{-11}} = 4.0 \\times \\frac{10^{-11}}{10^{-11}} = 4.0\n$$\nThe problem requires the final value to be rounded to $3$ significant figures. Therefore, we express $R$ as $4.00$.\n\nSince $R = \\frac{t_{diff}}{t_{adv}} = 4.00$, it implies that $t_{diff} = 4.00 \\times t_{adv}$. The characteristic time for diffusion is four times longer than the characteristic time for advection. This means that advection is the faster and, therefore, dominant mechanism for clearing amyloid-$\\beta$ over the given length scale under these conditions.", "answer": "$$\\boxed{4.00}$$", "id": "5071277"}, {"introduction": "Having established the importance of convection, we now turn to the cellular machinery that facilitates this fluid movement. The Aquaporin-4 ($AQP4$) water channels, densely packed on astrocyte endfeet, are thought to play a crucial role in regulating fluid exchange between the paravascular space and the brain interstitium. This practice provides a hands-on opportunity to model how the absence of these channels, as in a hypothetical knockout mouse, impacts the convective velocity and alters the Péclet number, thereby reducing the efficiency of glymphatic transport [@problem_id:5071332].", "problem": "A mouse cortical paravascular pathway is modeled as a one-dimensional conduit along which an inert fluorescent tracer is transported from the periarterial space into interstitial tissue. Assume the tracer concentration is a function of position and time, denoted by $c(x,t)$, and that transport arises from a combination of bulk fluid motion with speed $U$ and molecular diffusion with coefficient $D$. Consider two genotypes: wild type with polarized Aquaporin-4 (AQP4) at astrocyte endfeet, and Aquaporin-4 knockout (AQP4$^{-/-}$) that lacks endfoot polarization. The lack of Aquaporin-4 polarization reduces the measured convection velocity along the paravascular pathway.\n\nStarting from local mass conservation and the definition of diffusive flux, derive the governing one-dimensional transport equation for $c(x,t)$ and use non-dimensionalization based on a characteristic cortical length scale $L$ to identify the dimensionless group that compares advection to diffusion. Interpret how this dimensionless group controls tracer influx kinetics in the advection-dominated versus diffusion-dominated regimes.\n\nYou are provided the following scientifically plausible parameters measured under light urethane anesthesia with two-photon imaging of penetrating arterioles:\n- Wild-type convection velocity: $U_{\\mathrm{WT}} = 20 \\,\\mu\\mathrm{m}\\,\\mathrm{s}^{-1}$,\n- Aquaporin-4 knockout convection velocity: $U_{\\mathrm{KO}} = 7 \\,\\mu\\mathrm{m}\\,\\mathrm{s}^{-1}$,\n- Effective cortical transport length scale: $L = 1.5 \\,\\mathrm{mm}$,\n- Tracer diffusion coefficient in cortex: $D = 1.0 \\times 10^{-10} \\,\\mathrm{m}^{2}\\,\\mathrm{s}^{-1}$.\n\nDefine the Péclet number as the advection-to-diffusion ratio obtained from your non-dimensionalization. Compute the change in Péclet number due to Aquaporin-4 knockout, defined as\n$$\\Delta \\mathrm{Pe} = \\mathrm{Pe}_{\\mathrm{KO}} - \\mathrm{Pe}_{\\mathrm{WT}}.$$\nExpress your final answer as a pure number (dimensionless) and round your result to three significant figures.", "solution": "The problem is evaluated to be scientifically grounded, well-posed, objective, and complete. All necessary physical parameters and functional relationships are provided to derive the governing equation, perform the non-dimensionalization, and calculate the requested quantity. The physical context of glymphatic transport and the parameter values are consistent with established neurobiological and biophysical literature. The problem is therefore deemed valid and a solution will be provided.\n\nThe transport of an inert tracer with concentration $c(x,t)$ in a one-dimensional conduit is governed by the principle of mass conservation. Consider a small control volume of length $\\Delta x$ and constant cross-sectional area $A$ located between position $x$ and $x+\\Delta x$. The rate of change of the amount of tracer within this volume is equal to the net rate at which the tracer flows into the volume.\n\nThe total mass of tracer in the control volume is given by $\\int_{x}^{x+\\Delta x} c(x',t) A \\, dx'$. The time rate of change of this mass is:\n$$ \\frac{\\partial}{\\partial t} \\int_{x}^{x+\\Delta x} A c(x',t) \\, dx' $$\nThe total flux, $J(x,t)$, is the sum of the advective flux, $J_{\\mathrm{adv}}$, due to bulk fluid motion, and the diffusive flux, $J_{\\mathrm{diff}}$, due to molecular diffusion. The advective flux is given by $J_{\\mathrm{adv}} = U c(x,t)$, where $U$ is the bulk fluid velocity. The diffusive flux is described by Fick's first law, $J_{\\mathrm{diff}} = -D \\frac{\\partial c(x,t)}{\\partial x}$, where $D$ is the diffusion coefficient. The total flux is therefore:\n$$ J(x,t) = J_{\\mathrm{adv}} + J_{\\mathrm{diff}} = U c(x,t) - D \\frac{\\partial c(x,t)}{\\partial x} $$\nThe net rate of flow into the control volume is the flux entering at $x$ minus the flux leaving at $x+\\Delta x$:\n$$ A J(x,t) - A J(x+\\Delta x, t) $$\nEquating the rate of change of mass to the net flux gives the integral form of the conservation law:\n$$ \\frac{\\partial}{\\partial t} \\int_{x}^{x+\\Delta x} A c(x',t) \\, dx' = A J(x,t) - A J(x+\\Delta x, t) $$\nAssuming $A$ is constant, we can divide by $A \\Delta x$:\n$$ \\frac{1}{\\Delta x} \\frac{\\partial}{\\partial t} \\int_{x}^{x+\\Delta x} c(x',t) \\, dx' = - \\frac{J(x+\\Delta x, t) - J(x,t)}{\\Delta x} $$\nTaking the limit as $\\Delta x \\to 0$, the left side becomes $\\frac{\\partial c(x,t)}{\\partial t}$ by the fundamental theorem of calculus, and the right side becomes $-\\frac{\\partial J(x,t)}{\\partial x}$ by the definition of the derivative. This yields the one-dimensional continuity equation:\n$$ \\frac{\\partial c}{\\partial t} = - \\frac{\\partial J}{\\partial x} $$\nSubstituting the expression for the total flux $J$:\n$$ \\frac{\\partial c}{\\partial t} = - \\frac{\\partial}{\\partial x} \\left( U c - D \\frac{\\partial c}{\\partial x} \\right) $$\nAssuming the velocity $U$ and diffusion coefficient $D$ are constant with respect to position $x$, we can expand the derivative on the right-hand side:\n$$ \\frac{\\partial c}{\\partial t} = -U \\frac{\\partial c}{\\partial x} + D \\frac{\\partial^2 c}{\\partial x^2} $$\nRearranging gives the one-dimensional advection-diffusion equation, which is the governing transport equation for $c(x,t)$:\n$$ \\frac{\\partial c}{\\partial t} + U \\frac{\\partial c}{\\partial x} = D \\frac{\\partial^2 c}{\\partial x^2} $$\nTo identify the dimensionless group that compares advection to diffusion, we non-dimensionalize this equation. Let's introduce the following dimensionless variables, denoted by a prime symbol:\n$$ x' = \\frac{x}{L}, \\quad t' = \\frac{t}{\\tau}, \\quad c' = \\frac{c}{C_0} $$\nHere, $L$ is the characteristic length scale, $\\tau$ is a characteristic time scale, and $C_0$ is a characteristic concentration. We use the chain rule to transform the derivatives:\n$$ \\frac{\\partial}{\\partial t} = \\frac{\\partial t'}{\\partial t} \\frac{\\partial}{\\partial t'} = \\frac{1}{\\tau} \\frac{\\partial}{\\partial t'} $$\n$$ \\frac{\\partial}{\\partial x} = \\frac{\\partial x'}{\\partial x} \\frac{\\partial}{\\partial x'} = \\frac{1}{L} \\frac{\\partial}{\\partial x'} $$\n$$ \\frac{\\partial^2}{\\partial x^2} = \\frac{1}{L^2} \\frac{\\partial^2}{\\partial x'^2} $$\nSubstituting these into the advection-diffusion equation:\n$$ \\frac{1}{\\tau} \\frac{\\partial (C_0 c')}{\\partial t'} + \\frac{U}{L} \\frac{\\partial (C_0 c')}{\\partial x'} = \\frac{D}{L^2} \\frac{\\partial^2 (C_0 c')}{\\partial x'^2} $$\nSince $C_0$ is a constant, we can divide it out:\n$$ \\frac{1}{\\tau} \\frac{\\partial c'}{\\partial t'} + \\frac{U}{L} \\frac{\\partial c'}{\\partial x'} = \\frac{D}{L^2} \\frac{\\partial^2 c'}{\\partial x'^2} $$\nTo make the equation dimensionless, we can multiply all terms by a factor to make one coefficient equal to $1$. A standard choice is to multiply by $\\frac{L^2}{D}$, which corresponds to choosing the diffusive time scale $\\tau = \\frac{L^2}{D}$:\n$$ \\frac{L^2}{D} \\frac{1}{\\tau} \\frac{\\partial c'}{\\partial t'} + \\frac{UL}{D} \\frac{\\partial c'}{\\partial x'} = \\frac{\\partial^2 c'}{\\partial x'^2} $$\nWith $\\tau = \\frac{L^2}{D}$, the equation becomes:\n$$ \\frac{\\partial c'}{\\partial t'} + \\left( \\frac{UL}{D} \\right) \\frac{\\partial c'}{\\partial x'} = \\frac{\\partial^2 c'}{\\partial x'^2} $$\nThe dimensionless group that multiplies the advective term, $\\frac{\\partial c'}{\\partial x'}$, is $\\frac{UL}{D}$. This group, defined as the Péclet number, $\\mathrm{Pe}$, directly compares the magnitude of advective transport to diffusive transport.\n$$ \\mathrm{Pe} = \\frac{UL}{D} = \\frac{\\text{advective transport rate}}{\\text{diffusive transport rate}} $$\nThe tracer influx kinetics are controlled by the Péclet number:\n-   If $\\mathrm{Pe} \\gg 1$ (advection-dominated regime), transport by bulk flow is much faster than by diffusion. Tracer particles are carried along with the fluid at speed $U$. This results in rapid and directional influx into the tissue.\n-   If $\\mathrm{Pe} \\ll 1$ (diffusion-dominated regime), molecular diffusion is the primary transport mechanism. The tracer spreads slowly and isotropically from regions of high concentration to low concentration. This results in slow, less-directed influx.\n\nWe are asked to compute the change in Péclet number, $\\Delta \\mathrm{Pe} = \\mathrm{Pe}_{\\mathrm{KO}} - \\mathrm{Pe}_{\\mathrm{WT}}$. The given parameters are:\n-   $U_{\\mathrm{WT}} = 20 \\,\\mu\\mathrm{m}\\,\\mathrm{s}^{-1} = 20 \\times 10^{-6} \\,\\mathrm{m}\\,\\mathrm{s}^{-1}$\n-   $U_{\\mathrm{KO}} = 7 \\,\\mu\\mathrm{m}\\,\\mathrm{s}^{-1} = 7 \\times 10^{-6} \\,\\mathrm{m}\\,\\mathrm{s}^{-1}$\n-   $L = 1.5 \\,\\mathrm{mm} = 1.5 \\times 10^{-3} \\,\\mathrm{m}$\n-   $D = 1.0 \\times 10^{-10} \\,\\mathrm{m}^{2}\\,\\mathrm{s}^{-1}$\n\nFirst, we calculate the Péclet number for the wild-type (WT) case:\n$$ \\mathrm{Pe}_{\\mathrm{WT}} = \\frac{U_{\\mathrm{WT}} L}{D} = \\frac{(20 \\times 10^{-6} \\,\\mathrm{m}\\,\\mathrm{s}^{-1}) \\times (1.5 \\times 10^{-3} \\,\\mathrm{m})}{1.0 \\times 10^{-10} \\,\\mathrm{m}^{2}\\,\\mathrm{s}^{-1}} $$\n$$ \\mathrm{Pe}_{\\mathrm{WT}} = \\frac{30 \\times 10^{-9}}{1.0 \\times 10^{-10}} = 300 $$\nNext, we calculate the Péclet number for the Aquaporin-4 knockout (KO) case:\n$$ \\mathrm{Pe}_{\\mathrm{KO}} = \\frac{U_{\\mathrm{KO}} L}{D} = \\frac{(7 \\times 10^{-6} \\,\\mathrm{m}\\,\\mathrm{s}^{-1}) \\times (1.5 \\times 10^{-3} \\,\\mathrm{m})}{1.0 \\times 10^{-10} \\,\\mathrm{m}^{2}\\,\\mathrm{s}^{-1}} $$\n$$ \\mathrm{Pe}_{\\mathrm{KO}} = \\frac{10.5 \\times 10^{-9}}{1.0 \\times 10^{-10}} = 105 $$\nFinally, we compute the change in the Péclet number:\n$$ \\Delta \\mathrm{Pe} = \\mathrm{Pe}_{\\mathrm{KO}} - \\mathrm{Pe}_{\\mathrm{WT}} = 105 - 300 = -195 $$\nThe result is $-195$, which has three significant figures as required. The negative value indicates that the loss of AQP4 polarization, by reducing convection velocity, leads to a significant decrease in the Péclet number, thus shifting the transport dynamics towards a less advection-dominated regime.", "answer": "$$ \\boxed{-195} $$", "id": "5071332"}, {"introduction": "The efficiency of the glymphatic system has profound implications for neurological health, particularly in the context of aging and neurodegenerative diseases. When clearance mechanisms are impaired, waste products like amyloid-$\\beta$ can accumulate to toxic levels. This final practice utilizes a simplified pharmacokinetic model to simulate this process, allowing you to calculate the new steady-state concentration of amyloid-$\\beta$ that results from a specific reduction in glymphatic clearance, as is hypothesized to occur in Alzheimer's disease [@problem_id:5071303].", "problem": "Aging and Alzheimer’s disease (AD) can impair glymphatic paravascular clearance of soluble amyloid-$\\beta$ from the brain interstitial fluid (ISF). Consider a single well-mixed ISF compartment in which soluble amyloid-$\\beta$ concentration, denoted $C(t)$, evolves according to conservation of mass with a constant production rate and parallel first-order clearance pathways. Let the constant production rate be $S$ (in $\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}$). Clearance occurs via two independent first-order processes: glymphatic paravascular clearance with rate constant $k_{g}$ (in $\\mathrm{h}^{-1}$) and non-glymphatic clearance (enzymatic degradation and blood–brain barrier transport) with rate constant $k_{n}$ (in $\\mathrm{h}^{-1}$). Assume the well-mixed and first-order approximations are valid over the timescales of interest.\n\nIn a healthy adult at baseline, suppose $S = 0.015\\,\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}$, $k_{g} = 0.10\\,\\mathrm{h}^{-1}$, and $k_{n} = 0.05\\,\\mathrm{h}^{-1}$. In Alzheimer’s disease (AD), assume that the glymphatic paravascular clearance rate constant decreases by $40\\%$ relative to the healthy value, while $S$ and $k_{n}$ remain unchanged.\n\nStarting from conservation of mass applied to a well-mixed compartment with first-order loss terms, derive the expression for the steady-state concentration $C_{\\mathrm{ss}}$ and use it to compute the new steady-state amyloid-$\\beta$ concentration in AD. Express your final answer in $\\mu\\mathrm{M}$ and round to $4$ significant figures.", "solution": "The problem will first be validated against the required criteria.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\n- The system is a single well-mixed interstitial fluid (ISF) compartment.\n- Amyloid-$\\beta$ concentration is denoted by $C(t)$.\n- The evolution of $C(t)$ is governed by conservation of mass.\n- There is a constant production rate, $S$, with units of $\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}$.\n- Clearance occurs via two independent, parallel first-order processes.\n- The glymphatic paravascular clearance rate constant is $k_{g}$ (in $\\mathrm{h}^{-1}$).\n- The non-glymphatic clearance rate constant is $k_{n}$ (in $\\mathrm{h}^{-1}$).\n- The well-mixed and first-order approximations are valid.\n- Healthy adult baseline values:\n  - $S = 0.015\\,\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}$\n  - $k_{g} = 0.10\\,\\mathrm{h}^{-1}$\n  - $k_{n} = 0.05\\,\\mathrm{h}^{-1}$\n- Alzheimer’s disease (AD) conditions:\n  - The glymphatic clearance rate constant $k_{g}$ decreases by $40\\%$ relative to the healthy value.\n  - $S$ and $k_{n}$ remain unchanged.\n- The task is to derive the expression for the steady-state concentration $C_{\\mathrm{ss}}$, compute its value in AD, and provide the result in $\\mu\\mathrm{M}$ rounded to $4$ significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n\n1.  **Scientifically Grounded:** The problem statement is based on established principles of pharmacokinetics and neurobiology. The model of a well-mixed compartment with constant production and first-order clearance is a standard and valid simplification used to study the dynamics of substances in biological systems. The context of amyloid-$\\beta$ clearance via the glymphatic system and its impairment in Alzheimer's disease is a topic of current scientific research. The problem does not violate any fundamental principles.\n2.  **Well-Posed:** The problem is well-posed. It provides all necessary parameters ($S$, $k_g$, $k_n$) and the specific change in one parameter for the AD case. The objective is clearly defined: find the new steady-state concentration. A unique, stable steady-state solution exists for the described system.\n3.  **Objective:** The problem is stated in precise, quantitative, and objective language, free from subjective or ambiguous terminology.\n\n**Step 3: Verdict and Action**\n\nThe problem is deemed **valid**. It is scientifically grounded, well-posed, and objective. It contains no contradictions, missing information, or other flaws. Therefore, I will proceed with the solution.\n\n### Solution\n\nThe evolution of the amyloid-$\\beta$ concentration, $C(t)$, in the well-mixed ISF compartment is described by the principle of mass conservation. The rate of change of concentration is the sum of the rate of production and the rate of clearance.\nThe governing ordinary differential equation is:\n$$\n\\frac{dC(t)}{dt} = (\\text{Rate of production}) - (\\text{Rate of clearance})\n$$\nThe production rate is given as a constant, $S$. The units of $S$ ($\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}$) imply it is the rate of concentration increase due to production.\n$$\n\\text{Rate of production} = S\n$$\nClearance is composed of two parallel first-order processes. A first-order process has a rate proportional to the concentration $C(t)$. The total clearance rate is the sum of the rates of the two parallel pathways:\n$$\n\\text{Rate of clearance} = (\\text{Rate via glymphatic pathway}) + (\\text{Rate via non-glymphatic pathway})\n$$\n$$\n\\text{Rate of clearance} = k_{g}C(t) + k_{n}C(t) = (k_{g} + k_{n})C(t)\n$$\nCombining these terms, we obtain the differential equation for $C(t)$:\n$$\n\\frac{dC(t)}{dt} = S - (k_{g} + k_{n})C(t)\n$$\nAt steady state, the concentration is constant, which means its time derivative is zero. Let $C_{\\mathrm{ss}}$ denote the steady-state concentration.\n$$\n\\frac{dC_{\\mathrm{ss}}}{dt} = 0\n$$\nSubstituting this condition into the differential equation gives:\n$$\n0 = S - (k_{g} + k_{n})C_{\\mathrm{ss}}\n$$\nSolving for $C_{\\mathrm{ss}}$ yields the general expression for the steady-state concentration:\n$$\n(k_{g} + k_{n})C_{\\mathrm{ss}} = S\n$$\n$$\nC_{\\mathrm{ss}} = \\frac{S}{k_{g} + k_{n}}\n$$\nThis is the derived expression for the steady-state concentration.\n\nNext, we apply this formula to the case of Alzheimer's disease (AD). Let the parameters for the healthy case be $S$, $k_{g, \\text{healthy}}$, and $k_n$. For the AD case, the parameters are $S$, $k_{g, \\text{AD}}$, and $k_n$.\nThe given values are:\n- $S = 0.015\\,\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}$ (unchanged)\n- $k_n = 0.05\\,\\mathrm{h}^{-1}$ (unchanged)\n- $k_{g, \\text{healthy}} = 0.10\\,\\mathrm{h}^{-1}$\n\nIn AD, the glymphatic clearance rate constant $k_g$ decreases by $40\\%$. The new value, $k_{g, \\text{AD}}$, is therefore $100\\% - 40\\% = 60\\%$ of the healthy value.\n$$\nk_{g, \\text{AD}} = k_{g, \\text{healthy}} \\times (1.0 - 0.40) = 0.10\\,\\mathrm{h}^{-1} \\times 0.60 = 0.06\\,\\mathrm{h}^{-1}\n$$\nNow we can compute the new steady-state concentration in AD, denoted as $C_{\\mathrm{ss, AD}}$, using the derived formula and the AD parameters:\n$$\nC_{\\mathrm{ss, AD}} = \\frac{S}{k_{g, \\text{AD}} + k_n}\n$$\nSubstituting the numerical values:\n$$\nC_{\\mathrm{ss, AD}} = \\frac{0.015\\,\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}}{0.06\\,\\mathrm{h}^{-1} + 0.05\\,\\mathrm{h}^{-1}}\n$$\n$$\nC_{\\mathrm{ss, AD}} = \\frac{0.015\\,\\mu\\mathrm{M}\\,\\mathrm{h}^{-1}}{0.11\\,\\mathrm{h}^{-1}}\n$$\n$$\nC_{\\mathrm{ss, AD}} = \\frac{0.015}{0.11}\\,\\mu\\mathrm{M} \\approx 0.13636363... \\,\\mu\\mathrm{M}\n$$\nThe problem requires the answer to be rounded to $4$ significant figures.\n$$\nC_{\\mathrm{ss, AD}} \\approx 0.1364\\,\\mu\\mathrm{M}\n$$", "answer": "$$\n\\boxed{0.1364}\n$$", "id": "5071303"}]}